Tu Youyou's team: New breakthrough in research on 'artemisinin resistance'
After years of hard work, Tu Youyou and her team have made new breakthroughs in the areas of "anti-malarial mechanism research", "causes of drug resistance" and "adjustment of treatment methods", and recently proposed practical treatment solutions to deal with the problem of "artemisinin resistance", and made new progress in "artemisinin treatment for lupus erythematosus and other indications" and "the export of traditional Chinese medicine scientific research papers", which have been highly recognized by the World Health Organization and authoritative experts at home and abroad.
Professor Cox, editor-in-chief of the Oxford Textbook of Medicine, said he was pleased with the upcoming inclusion of traditional Chinese medicine treatises in the textbook. He said: "The chapter on Chinese medicine is both important and in-depth. It is all the result of the outstanding efforts of Chinese scientists." Pedro Alonso and other leading experts believe that Tu Youyou's team has built a bridge between traditional medicine and modern medicine, allowing Chinese medicine to be not only widely used in China, but also recognized in more and more countries for its effective treatment. We hope Chinese scientists will continue to make more noise in the international arena of artemisinin research.
Chinese Medicine Innovation Development
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
24th Pharma Asia International Exhibition & Conferences to Open in Karachi, Pakistan
-
GLP-1 API Route to U.S. Abruptly Narrows: FDA Heavily Penalizes U.S. Compounding Pharmacy and Bypasses Warning Letter to Ban Chinese Factory
-
China's Ibuprofen Export Performance, First Half of 2026
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
The relationship between Digital Transformation and Work- Life Balance in the Egyptian Pharmaceutical Industry
-
What Does the Future Hold for the Anti-Obesity Drug Market in 2024?
-
Hengrui entered the top 20 for the first time. How big is the gap between Chinese and American pharmaceutical companies?
-
The State Food and Drug Administration accepted the marketing application of Ditze Pharma suvortinib
-
Jimin's innovative polycystic kidney disease innovative drug was approved by the FDA for clinical trials
-
Another giant may be broken up
Recommend Reading
-
Chinese Urea Producers Receive a Timely Boost as Second Round of 2026 Export Quotas Nears 2 Million Tons
-
Major Fire Hits China-Russia Joint 2.7 Million T/Y Polyolefins Project, Killing 6 Chinese Nationals and Injuring 152 People
-
Wanhua's BorsodChem Restarts 650,000 T/Y of MDI and TDI Capacity in Europe
-
EU Low-Value Parcel Rules Could Disrupt Chemical Sample Flows
-
EU May Build Industry-Level Trade Barriers Against Chinese Chemicals
-
January Phosphate Market Steady with an Uplift in China
-
January China Titanium Dioxide Market Prices Increase
-
This week, the Chinese anhydrous hydrogen fluoride market showed a slight upward fluctuation (1.26-1.29)
-
This week, the 180CST fuel oil market in China fluctuated and rose
-
January Benzene Market Trend Summary (January 1, 2026 - January 29, 2026) in China